e-learning
resources
Vienna 2009
Tuesday, 15.09.2009
Pathobiology of pulmonary vascular diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Carvedilol partially reverses maladaptive remodeling and improves function of the right ventricle (RV) in experimentally-induced pulmonary arterial hypertension (PAH)
H. Bogaard, R. Natarajan, D. Kraskauskas, N. Voelkel (Richmond, United States Of America; Amsterdam, Netherlands)
Source:
Annual Congress 2009 - Pathobiology of pulmonary vascular diseases
Session:
Pathobiology of pulmonary vascular diseases
Session type:
E-Communication Session
Number:
4329
Disease area:
Interstitial lung diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Bogaard, R. Natarajan, D. Kraskauskas, N. Voelkel (Richmond, United States Of America; Amsterdam, Netherlands). Carvedilol partially reverses maladaptive remodeling and improves function of the right ventricle (RV) in experimentally-induced pulmonary arterial hypertension (PAH). Eur Respir J 2009; 34: Suppl. 53, 4329
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Urocortin-2 improves right ventricular function and attenuates experimental pulmonary arterial hypertension
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018
Effect of sitaxentan on haemodynamics and right ventricular hypertrophy in monocrotaline-induced pulmonary arterial hypertension (PAH)
Source: Annual Congress 2008 - Pulmonary vascular biology
Year: 2008
Lodenafil improves hemodynamics and right ventricular remodeling in monocrotaline-induced model of pulmonary arterial hypertension in rats
Source: Annual Congress 2010 - Experimental pulmonary hypertension
Year: 2010
Combining bosentan and sildenafil improves mitochondrial capacity and restores right ventricular contractility in established pulmonary hypertension
Source: Annual Congress 2007 - Pathogenesis and novel therapeutic targets in pulmonary hypertension
Year: 2007
How prostacyclin therapy improves right ventricular function in pulmonary arterial hypertension
Source: Eur Respir J, 50 (2) 1700764; 10.1183/13993003.00764-2017
Year: 2017
Right ventricular stiffness impairs right atrial function in pulmonary arterial hypertension
Source: Virtual Congress 2020 – Right ventricular function and pulmonary hypertension
Year: 2020
Bosentan combined with sildenafil prevents right ventricular hypoxia in pulmonary arterial hypertension
Source: Annual Congress 2008 - Pathophysiology of pulmonary hypertension
Year: 2008
In a model of genetic pulmonary hypertension, VIP attenuates pulmonary vascular remodeling and right ventricular hypertrophy
Source: Annual Congress 2007 - Pathogenesis and novel therapeutic targets in pulmonary hypertension
Year: 2007
Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2008; 31: 1160-1166
Year: 2008
Macitentan treatment improves the dysfunctional right ventricle in a sugen/hypoxic rat model of pulmonary hypertension
Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench
Year: 2019
Isolated diastolic dysfunction of right ventricle: stress-induced pulmonary hypertension
Source: Eur Respir J 2008; 31: 475-476
Year: 2008
Adrenergic receptor blocker reverses cardiac metabolic remodeling and improves right ventricular function in experimental pulmonary hypertension
Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease
Year: 2011
Increased right ventricular cardiomyocyte stiffness in patients with pulmonary arterial hypertension
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology
Year: 2012
Improved right ventricular function after substantial afterload reduction in patients with pulmonary arterial hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical treatment
Year: 2012
Amelioration of right ventricular morphology and systolic function in patients with severe group 3 pulmonary hypertension treated with pulmonary vasodilators
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
The heat shock protein 90 inhibitor, 17-AAG, ameliorates pulmonary arteriolar and right ventricular hypertrophy in monocrotaline-induced pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary circulation II
Year: 2009
Right ventricular function and lung perfusion in adaptive versus maladaptive experimental pulmonary hypertension
Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension
Year: 2021
Vascular and right ventricular remodelling in chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2013; 41: 224-232
Year: 2013
Impaired right ventricular diastolic function in systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension
Source: Annual Congress 2008 - Pulmonary vascular medicine
Year: 2008
Macitentan in pulmonary hypertension due to left ventricular dysfunction
Source: Eur Respir J, 51 (2) 1701886; 10.1183/13993003.01886-2017
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept